Rheumatology Specialty Positions (New)

Quote






Well I think it's an exciting opportunity to sell a first in class drug. I would rather be selling something new with a contract company that selling an old drug like Crestor about to go off patent for a manufacturer.

Rheums are a nice specialty to call on anyway.
 






Anonymous said:
Well I think it's an exciting opportunity to sell a first in class drug. I would rather be selling something new with a contract company that selling an old drug like Crestor about to go off patent for a manufacturer.

Rheums are a nice specialty to call on anyway.
Click to expand...

Are rheums from another planet?

Just curious because I got rejected for this job despite calling on about 4 different specialits, and my guess was because I never called on rheums.

Its not a big deal, because I would have been looking for another job in 17 months! LOL>
 






Rheums are generally nice and receptive since they treat patients who generally have no hope to improve - they welcome new treatments for their patients with chronic debilitating illnesses. I remember when the DMARDs first came out and how excited they were to finally have something new to offer. Tofa might be similar in it's reception (getting it covered by MCOs may be a different story, especially first line).

That being said, I agree with the posters that feel that this is a bandaid at best. Pfizer is in trouble due to the delay in Eliquis, and will look to cut expenses in the near future if things do not pan out well with this drug. They could look toward their own, or end a contract early (or not renew). But if you need the check, or the experience - it wouldn't be a bad opportunity.
 












Anonymous said:
Rheums are generally nice and receptive since they treat patients who generally have no hope to improve - they welcome new treatments for their patients with chronic debilitating illnesses. I remember when the DMARDs first came out and how excited they were to finally have something new to offer. Tofa might be similar in it's reception (getting it covered by MCOs may be a different story, especially first line).

That being said, I agree with the posters that feel that this is a bandaid at best. Pfizer is in trouble due to the delay in Eliquis, and will look to cut expenses in the near future if things do not pan out well with this drug. They could look toward their own, or end a contract early (or not renew). But if you need the check, or the experience - it wouldn't be a bad opportunity.
Click to expand...

Bandaid? You are on crack. This drug will light up the switchboards. It will be written and approved. Maybe a PA in the early stages but any insurance company looking at cost will jump all over this. A pill will be cheaper than a needle.
 






Anonymous said:
Bandaid? You are on crack. This drug will light up the switchboards. It will be written and approved. Maybe a PA in the early stages but any insurance company looking at cost will jump all over this. A pill will be cheaper than a needle.
Click to expand...

Who cares if it lights up the scoreboard?

You are not going to get paid a great bonus for it, I can guarantee you that. Pfizer has the safeguards in place to protect themselves, in case it exceeds expectations.

Welcome to the wonderful world of socialist selling, common in pharma.
 






Anonymous said:
Who cares if it lights up the scoreboard?

You are not going to get paid a great bonus for it, I can guarantee you that. Pfizer has the safeguards in place to protect themselves, in case it exceeds expectations.

Welcome to the wonderful world of socialist selling, common in pharma.
Click to expand...

Yep - I would not touch this contract job with a ten foot pole! Publicis are liars and it is highly unlikely Pfizer will ever hire the contract reps directly.
 






Anonymous said:
Yep - I would not touch this contract job with a ten foot pole! Publicis are liars and it is highly unlikely Pfizer will ever hire the contract reps directly.
Click to expand...



Pfizer hired a few Publicis reps, probably the ones that were so good at brown nosing.

So, there you have it. Pharma is totally becoming a joke.

Best bet is to find a company that will INVEST in YOU. Now, this is not happeing at PSS or Pfizer or pharma, so you have to look outside of the industry.

If you are in a spot where you can't find a company that will invest in you, then my suggestion is to invest in yourself, through school or starting a business having to do with something you know a lot about.

With the direction this country is going, people need to face the reality that pharma is left over for the soul-less people in this world, with little talent and lots of "yes" man mentality.

This industry has taught us to not think for ourselves, and to be "yes" men. But, now its time to change that.
 


















Anonymous said:
coveted spots? please tell me you are joking.
Click to expand...

The way people think about jobs today is pathetic.

They just like to continue to let companies take a dump on them, and then pretend that such jobs are "coveted".

What people do for money, and they why people lower their standards for money, is one of the mysteries of this world that I will never understand.
 
























Anonymous said:
Four time President's award achiever and an unsurpassed portfolio and a good deal of Rheumatology experience. I was turned down.
Click to expand...

So who did they hire instead of you? A five time president's award achiever? Someone with 30 years experience calling on Rheums who has good relationships with both the docs and the caterers in the area?
 












Anonymous said:
No,that preson is obvoious to old to work for them.
Click to expand...

stupid, that is discrimination.

of course it happens all the time, and the reason they probably took a younger rep is:

a. salary expectations will be reasonable.

b. younger reps are easier to control.

c. pharma has no integrity.

I am surprised more of these "older" reps don't sue. They should, as they would put these companies in their place and these discrimination practices can stop.
 






It's happening to me and it is blatant.

Report: Age Discrimination High Among Pharma Sales Reps

Age discrimination is rife among pharmaceutical job seekers, according to anecdotal evidence gathered by MedZilla, a popular jobs database for workers in the biotech, pharma, healthcare and medical sector.

According to John Burkhardt, director of operations at the company, pharma companies are increasingly hiring younger and younger employees, based on what job seekers have said.

And in the MedZilla forums, frustrations are high among older job seekers over being told that they are "too experienced" or that the company is trying to "develop younger talent."

In these cases, Burkhadt advises to consider changing sectors entirely. There is a growing need for health care jobs serving older citizens, often creating demand for more experienced salespeople who can relate better with older customers.

Another option is to go back to school to brush up on skills. As digital capabilities become more and more important in the sales profession, including the use of social networks for lead generation, or new software for organizing prospects, employers may look at older candidates as being too out of touch.

If you're an older salesperson, you would do well to make sure you're familiar with digital skills and new technologies. Being labeled a "dinosaur" just doesn't sound so pleasant.
 












Top Bottom
Back
Quote